Dr. Ted Ling, MD, MS, DABR
Dr. Ted Ling is a board certified radiation oncologist serving the Palm Desert and Rancho Mirage areas. He is well versed in state-of-the-art modern radiation therapy techniques. Dr. Ling has authored and co-authored numerous peer-reviewed journal articles and book chapters in radiation therapy. Among these publications are investigations into methods of decreasing treatment toxicity during radiation therapy as well as interdisciplinary management of rare cancers.
Dr. Ling is a recipient of numerous awards including the RSNA Research & Education Foundation Roentgen Fellow Award and the American Brachytherapy Society Fellow Scholarship. He has been invited to speak and present research at both national and international cancer conferences. He also served as a journal reviewer and editorial board member for peer-reviewed radiation therapy publications.
Dr. Ling is particularly passionate about educating his patients with the knowledge they need to take charge of their cancer care. He also believes in treating each of his patients as he would one of his friends or family members. Each person is an individual with unique health goals. Dr. Ling works with all of his patients in becoming their partner in health and seeks to help them achieve the best possible outcome.
Treatments Performed:
Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT), Intensity-Modulated Radiotherapy (IMRT), 3D-Conformal Radiotherapy (3D-CRT), High-Dose Rate (HDR) Brachytherapy, Electron Radiotherapy
Specialty :
Radiation Oncology
Board Certified
Diplomate of the American Board of Radiology
Education :
MD, Saint Louis University
MS, University of California, Los Angeles
BS, University of California, Los Angeles
Training :
Visiting Fellowship – University of California, Los Angeles
Visiting Fellowship – University of British Columbia
Residency – Loma Linda University Medical Center
Internship – Loma Linda University Medical Center
Disease Sites treated:
Head and Neck
Skin
Breast
Lung
Esophageal
Gastric
Liver
Colon
Rectal
Anal
Hepatobiliary
Bladder
Prostate
Sarcoma
Lymphoma
Uterine
Cervical
Vulvar
Brain and Central Nervous System
Awards and Honors
2014 ABR LDR Prostate Brachytherapy Scholarship 2012-2014 RSNA R&E Foundation Roentgen Fellow Research Award
2013 International Society of GI Oncology (ISGIO) Travel Grant
2012 LLU Annual Postgraduate Conference Award for Best Overall Abstract
2010 SLU Distinction in Research Award
2009 RSNA R&E Foundation Research Medical Student Grant
2009 St. Louis Brain Tumor Foundation Award
Publications and Presentations
Ling TC, Radiation-induced soft tissue sarcoma after prostate brachytherapy. Ann Mens Health Wellness 2017, 1(1), 1001.
Yeo I, Nookala P, Gordon I, Schulte RW, Barnes S, Ghebremedhin A, Wang N, Yang GY, Ling TC, Bush DA, Slater JD, Patyal B. Passive Proton Therapy vs. IMRT Planning Study with Focal Boost for Prostate Cancer. Radiation Oncology 2015, 10(1), 213; doi: 10.1186/s13014-015-0522-5
Ling TC, Slater JM, Nookala P, Mifflin R, Grove R, Ly AM, Patyal B, Slater JD, Yang GY. Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton Radiotherapy, and 3D Conformal Radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients. Cancers 2014, 6(4), 2356-2368; doi:10.3390/cancers6042356
Ling TC, Slater JM, Mifflin R, Nookala P, Grove R, Ly AM, Patyal B, Slater JD, Yang GY. Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848. J Gastrointest Oncol 2014. Doi: 10.3978/j.issn.2078-6891.2014.094
Slater JM, Ling TC, Mifflin R, Nookala P, Grove R, Ly AM, Patyal B, Slater JD, Yang GY. Protons offer reduced tissue exposure for patients receiving radiation therapy for pancreatic cancer. The International Journal of Particle Therapy 2014. Doi: 10.14338/IJPT-14-00008.1
Ling TC, Slater JM, Senthil M, Kazanjian K, Howard F, Garberoglio CA, Slater JD, Yang GY. Surgical and radiation therapy management of recurrent anal melanoma. J Gastrointest Oncol 2014. Doi: 10.3978/j.issn.2078-6891.2013.050
Slater JM, Ling TC, Slater JD, Yang GY. Palliative radiation therapy for primary gastric melanoma. J Gastrointest Oncol 2014. Doi: 10.3978/j.issn.2078-6891.2013.057
Schulte RW, Ling TC. (2012). Early and late responses to ion beam irradiation. In Ion Beam Therapy (pp. 61-79). Berlin, Germany: Springer
Ling TC, Kang JI, Bush DA, Slater JD, Yang GY. Proton therapy for hepatocellular carcinoma. Chin J Cancer Res 2012;4:361-7
Ling TC, Kang JI, Slater JD, Yang GY. Proton therapy for gastrointestinal cancers.Transl Cancer Res 2012;3:150-8
Kang JI, Ling TC, Slater JD, Yang GY. Stereotactic body proton therapy for liver metastases.Transl Cancer Res 2012;4:271-5
Ostrowski RP, Schulte RW, Nie Y, Ling TC, Lee T, Manaenko A, Gridley DS, Zhang JH. Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model. Trans Stroke Res 2012;4:473-481
Ling TC, Manepalli J, Grossberg G. Electroconvulsive therapy in the presence of a metallic skull plate after meningioma resection. J ECT 2010;2:136-8
Schulte RW, Wroe A, Bashkirov V, Ling TC, Patyal B. Nanodosimetry as a tool for predicting the RBE of therapeutic proton beams. Med Phys 2009, 36(6)
